You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 8, August 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Critical Situations: Dermatology in the Acute Care Setting
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Venous Thromboembolism
 •Cardiovascular System
 •Immunotherapy
 •Alert me on articles by topic

Stroke and Deep Venous Thrombosis Complicating Intravenous Immunoglobulin Infusions

Kenneth A. Katz, MD, MSc; Chad M. Hivnor, MD; David E. Geist, BA; Michael Shapiro, MD; Michael E. Ming, MD; Victoria P. Werth, MD

Arch Dermatol. 2003;139:991-993.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF CASES

CASE 1

A 67-year-old woman had a 4-year history of dermatomyositis manifesting as a heliotrope rash, shawl sign, Gottron papules, proximal upper and lower extremity muscle weakness, and dysphagia. The creatine kinase level was 424 U/L (reference range, 2-150 U/L) and the erythrocyte sedimentation rate was 40 mm/h (reference range, 0-25 mm/h). Results of the remainder of the laboratory examination, including globulin levels, were within normal limits. Recent screening colonoscopy, mammography, Papanicolaou smear, and cancer antigen 125 levels showed no evidence of malignancy. She was refractory to a treatment regimen of prednisolone, 60 mg/d; mycophenolate mofetil, 750 mg twice daily; and chloroquine, 250 mg/d. She had not tolerated azathioprine or methotrexate, and trials of quinacrine and hydroxychloroquine had failed. She had chronic hypertension, which was controlled with ramipril, . . . [Full Text of this Article]

CASE 2

THERAPEUTIC CHALLENGE

COMMENT

University of Pennsylvania Medical Center, Philadelphia (Drs Katz, Hivnor, Shapiro, Ming, and Werth), and Yale University School of Medicine New Haven, Conn (Mr Geist)



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Frequency of Adverse Events Associated with Intravenous Immunoglobulin Therapy in Patients with Pemphigus or Pemphigoid
Gurcan and Ahmed
The Annals of Pharmacotherapy 2007;41:1604-1610.
ABSTRACT | FULL TEXT  

Acute stroke with high-dose intravenous immune globulin
White and Leonard
Am J Health Syst Pharm 2007;64:1611-1614.
ABSTRACT | FULL TEXT  

Review: intravenous immunoglobulin therapy and thromboembolic complications
Katz and Shoenfeld
Lupus 2005;14:802-808.
ABSTRACT  

Letter to the Editor
McCabe et al.
Lupus 2005;14:409-410.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.